Amarantus Bioscience Holdings' IPO

Amarantus Bioscience Holdings raised a round of funding on May 02, 2011. Investors include Public.

Amarantus BioScience Holdings (OTCQB: AMBS) is a biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases.…

Articles about Amarantus Bioscience Holdings' IPO: